DBV Technologies SA American (DBVT) Covered Calls

DBV Technologies SA is an epicutaneous immunotherapy company. The Company is engaged in research and development of patient-friendly therapy for food and pediatric allergy patients.

You can sell covered calls on DBV Technologies SA American to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for DBVT (prices last updated Fri 4:16 PM ET):

DBV Technologies SA American (DBVT) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
15.26 -0.12 15.26 19.95 314K - 0.0B
Covered Calls For DBV Technologies SA American (DBVT)
Expiration Strike Call Bid Net Debit Return
If Flat
Return If Flat
Dec 21 15 0.30 19.65 -23.7% -1081.3%
Jan 18 15 1.00 18.95 -20.8% -210.9%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial

Extended Business Description

DBV Technologies SA is a clinical-stage biopharmaceutical specialty company, which focuses on developing a novel technology platform called Viaskin. Viaskin is an electrostatic patch, which offers a convenient, self-administered, non-invasive immunotherapy to patients. It has designed two products candidates: Viaskin Peanut and Viaskin Milk. The company was founded by Pierre-Henri Benhamou, St├ęphane Benhamou, Bertrand Dupont, Christophe Dupont and Pierre-Yves Vannerom on March 29, 2002 and is headquartered in Bagneux, France.